The Impact of 7-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review

The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine

(2012) Sean P. Fitzwater et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults

(2011) Robert W Frenck et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections

(2011) Tirdad T Zangeneh et al.   Expert Review of Vaccines

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

(2011) Elizabeth Miller et al.   VACCINE

Impact of conjugate 7-valent vaccination in Belgium: Addressing methodological challenges

(2011) Germaine Hanquet et al.   VACCINE

Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States

(2011) L. Simonsen et al.   mBio

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

(2010) S. Esposito et al.   Clinical and Vaccine Immunology

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

(2010) Deborah Lehmann et al.   CLINICAL INFECTIOUS DISEASES

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

(2010) Zitta B. Harboe et al.   VACCINE

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule

(2010) Didrik F. Vestrheim et al.   VACCINE

Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project

(2010) Hope L. Johnson et al.   PLOS MEDICINE

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐AreaStreptococcus pneumoniaeResearch (CASPER) Study

(2009) James D. Kellner et al.   CLINICAL INFECTIOUS DISEASES

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain

(2009) M. Guevara et al.   CLINICAL MICROBIOLOGY AND INFECTION

Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine

(2009) E. Pérez-Trallero et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe

(2009) Markus Rose et al.   Expert Review of Vaccines

Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007

(2009) A. Fenoll et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006

(2009) Gregory J. Tyrrell et al.   VACCINE

National paediatric immunization program of high risk groups: No effect on the incidence of invasive pneumococcal diseases

(2009) P. Rendi-Wagner et al.   VACCINE

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

(2009) Simon Rückinger et al.   VACCINE

Declining invasive pneumococcal disease mortality in the United States, 1990–2005

(2009) Marifi Pulido et al.   VACCINE

Decreases in Case‐Fatality and Mortality Rates for Invasive Pneumococcal Disease in Olmsted County, Minnesota, during 1995–2007: A Population‐Based Study

(2008) Constantine Tsigrelis et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007

(2008) Carmen Ardanuy et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

(2008) Didrik F. Vestrheim et al.   VACCINE

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

(2007) C. Munoz-Almagro et al.   CLINICAL INFECTIOUS DISEASES